Adial Pharmaceuticals, Inc.

Ownership Transactions Reported by 10 Insiders

Symbol
ADIL on Nasdaq
Location
1180 Seminole Trail, Suite 495, Charlottesville, VA

There are no Buy or Sell transactions made by insiders since 10/11/2024

Adial Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
William B. Stilley III Director $3.46M May 23, 2023
Joseph Truluck Chief Financial Officer $726K Mar 25, 2024
Tony Goodman Chief Operating Officer, Director May 29, 2025
J. Kermit Anderson Director May 29, 2025
James W. Newman Jr. Director May 29, 2025
Robertson H. Gilliland Director May 29, 2025
Cary J. Claiborne Chief Executive Officer, Director May 29, 2025
Vinay Shah Chief Financial Officer May 29, 2025
Kevin Schuyler Director May 29, 2025
Bankole Johnson Director May 23, 2023

Recent Insider Transactions by Companies or Individuals for Adial Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.